NURO Stock - Neurometrix Inc.

NURO Stock Chart

NURO Profile

NeuroMetrix, Inc., a healthcare innovator founded in 1996 and based in Woburn, Massachusetts, specializes in the design, development, and global marketing of medical devices aimed at stimulating and analyzing nerve responses for both diagnostic and therapeutic applications. Operating across key markets including the United States, Europe, Japan, China, the Middle East, and Mexico, the company has established a strong presence in the healthcare technology sector.

The company's flagship products cater to diverse medical needs. DPNCheck, one of its leading offerings, serves as a nerve conduction test specifically designed to assess peripheral neuropathies such as diabetic peripheral neuropathy, addressing a critical diagnostic requirement within clinical settings. Additionally, NeuroMetrix's Quell is a wearable device engineered to provide symptomatic relief and management of chronic pain, offering patients an innovative non-pharmacological treatment option.

Further expanding its product portfolio, NeuroMetrix has developed the ADVANCE system, a versatile platform tailored for conducting nerve conduction studies. This comprehensive system supports healthcare professionals including managed care organizations, endocrinologists, podiatrists, primary care physicians, and specialists such as pain medicine physicians, neurologists, and orthopedic surgeons.

With a commitment to advancing healthcare through technology, NeuroMetrix continues to drive innovation in medical device solutions, empowering healthcare providers with advanced tools to enhance diagnostic accuracy and therapeutic outcomes for patients globally.

NURO Revenue Chart

NURO Earnings

Analyst Ratings